ClinicalTrials.Veeva

Menu

Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.

F

Fondazione G.B. Bietti, IRCCS

Status

Enrolling

Conditions

Glaucoma

Study type

Observational

Funder types

Other

Identifiers

NCT06227611
GLC04-20

Details and patient eligibility

About

The aim of the study is to evaluate the agreement between three different grids in detecting central visual field defect in early glaucoma patients with reduced ganglion cell layer thickness.

Enrollment

16 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • glaucoma patients with glaucomatous optic nerve head defect and reduced ganglion cell layer thickness

Exclusion criteria

  • age<18 years
  • unable to read, understand and sign the written informed consent
  • unable to perform visual field test
  • advanced glaucoma with C/D>0.7
  • other causes of optic neuropathies
  • retinal or macular diseases
  • lens or corneal opacities
  • spherical refractive defect >± 6D
  • cylindric refractive defect >± 3D

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems